| Surgery: Joint and Type | Post-Operative Infection: Type and Organism | Patient Risk Profile | Management |
|---|---|---|---|
| Knee arthroplasty, primary | Joint Space Infection, Coagulase negative Staph | Chronic viral hepatitis | Drained seroma, antibiotics; eventual resection with spacer and further revision required |
| Knee arthroplasty, revision | Joint Space Infection, S. aureus | Prednisone 15 mg/day, coronary artery disease | Surgical debridement, antibiotics, revision surgery |
| Knee arthroplasty, primary | Deep incisional, S. aureus and Enterococcus | Prednisone 10 mg/day, obesity, diabetes, coronary artery disease, hypertension | Surgical debridement, prolonged antibiotics |
| Knee arthroplasty, primary | Deep incisional, no organism cultured | None | Wound debridement, removal of hematoma, antibiotics |
| Hip arthroplasty, revision for fracture | Deep incisional, Enterococcus faecalis | Prednisone 17.5 mg daily, hypertension, diabetes, coronary artery disease, osteomyelitis foot | Incision and drainage, prolonged antibiotics |
| Hip arthroplasty, primary | Urinary tract | Leflunomide and adalimumab, hypertension | Antibiotics |
| Hip arthroplasty, primary | Urinary tract | Prednisone 10 mg/day, age >65 | Antibiotics |
| Knee arthroplasty, revision | Cellulitis of posterior shin | Age >65, coronary artery disease | Antibiotics |
| Knee arthroplasty, primary | Pneumonia | Prednisone 5 mg/day, Leflunomide, age >65 | Antibiotics |